Bio-Bridge, Lanzhou Roya Biotechnology Co. Ltd. deal

BGES signed a non-binding letter of intent to acquire 51% of Lanzhou, a bovine serum manufacturer. BGES said the acquisition will enable it to build a distribution network in China and begin earning r...